Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pancreatic cancer
Jörg Kleeff, Murray Korc, Minoti V. Apte, et al.
Nature Reviews Disease Primers (2016) Vol. 2, Iss. 1
Closed Access | Times Cited: 1559

Showing 1-25 of 1559 citing articles:

Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
John P. Neoptolemos, Daniel H. Palmer, Paula Ghaneh, et al.
The Lancet (2017) Vol. 389, Iss. 10073, pp. 1011-1024
Open Access | Times Cited: 1739
Global Burden of 5 Major Types of Gastrointestinal Cancer
Melina Arnold, Christian C. Abnet, Rachel Ε. Neale, et al.
Gastroenterology (2020) Vol. 159, Iss. 1, pp. 335-349.e15
Open Access | Times Cited: 1447
Therapeutic developments in pancreatic cancer: current and future perspectives
John P. Neoptolemos, Jörg Kleeff, Patrick Michl, et al.
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 6, pp. 333-348
Closed Access | Times Cited: 975
The Frequency of Ras Mutations in Cancer
Ian A. Prior, Fiona E. Hood, James L. Hartley
Cancer Research (2020) Vol. 80, Iss. 14, pp. 2969-2974
Open Access | Times Cited: 796
Molecular subtypes of pancreatic cancer
Eric A. Collisson, Peter J. Bailey, David K. Chang, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 4, pp. 207-220
Closed Access | Times Cited: 769
Optimizing the outcomes of pancreatic cancer surgery
Oliver Strobel, John P. Neoptolemos, Dirk Jäger, et al.
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 1, pp. 11-26
Closed Access | Times Cited: 729
Early Detection of Pancreatic Cancer: Opportunities and Challenges
Aatur D. Singhi, Eugene J. Koay, Suresh T. Chari, et al.
Gastroenterology (2019) Vol. 156, Iss. 7, pp. 2024-2040
Open Access | Times Cited: 620
Pancreatic cancer: Advances and challenges
Christopher J. Halbrook, Costas A. Lyssiotis, Marina Pasca di Magliano, et al.
Cell (2023) Vol. 186, Iss. 8, pp. 1729-1754
Open Access | Times Cited: 576
Chemoresistance in Pancreatic Cancer
Siyuan Zeng, Marina Pöttler, Bin Lan, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4504-4504
Open Access | Times Cited: 509
Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer
Matteo Ligorio, Srinjoy Sil, Jose Malagon-Lopez, et al.
Cell (2019) Vol. 178, Iss. 1, pp. 160-175.e27
Open Access | Times Cited: 437
Pancreatic Cancer Chemoresistance to Gemcitabine
Manoj Amrutkar, Ivar P. Gladhaug
Cancers (2017) Vol. 9, Iss. 11, pp. 157-157
Open Access | Times Cited: 401
Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches
Michael Orth, Philipp Metzger, S. Gerum, et al.
Radiation Oncology (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 400
Pancreatic cancer: A review of epidemiology, trend, and risk factors
Jian-Xiong Hu, Chengfei Zhao, Chen WenBiao, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 27, pp. 4298-4321
Open Access | Times Cited: 390
Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities
Vinod P. Balachandran, Gregory L. Beatty, Stephanie K. Dougan
Gastroenterology (2019) Vol. 156, Iss. 7, pp. 2056-2072
Open Access | Times Cited: 388
Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches
Talha Bin Emran, Asif Shahriar, Aar Rafi Mahmud, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 357
Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma
Eric Van Cutsem, Margaret A. Tempero, Darren Sigal, et al.
Journal of Clinical Oncology (2020) Vol. 38, Iss. 27, pp. 3185-3194
Open Access | Times Cited: 340
Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173/STING-dependent DNA sensor pathway
Enyong Dai, Leng Han, Jiao Liu, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 319
Stromal biology and therapy in pancreatic cancer: ready for clinical translation?
Albrecht Neeße, Christian Bauer, Daniel Öhlund, et al.
Gut (2018) Vol. 68, Iss. 1, pp. 159-171
Open Access | Times Cited: 303
m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling
Bo Tang, Yihua Yang, Min Kang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 262
CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer
Brooke A. Pereira, Claire Vennin, Michael Papanicolaou, et al.
Trends in cancer (2019) Vol. 5, Iss. 11, pp. 724-741
Open Access | Times Cited: 259
Cell death in pancreatic cancer: from pathogenesis to therapy
Xin Chen, Herbert J. Zeh, Rui Kang, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 11, pp. 804-823
Closed Access | Times Cited: 247
Gemcitabine loaded autologous exosomes for effective and safe chemotherapy of pancreatic cancer
Yongjiang Li, Junyong Wu, Jiemin Wang, et al.
Acta Biomaterialia (2019) Vol. 101, pp. 519-530
Closed Access | Times Cited: 246
Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution
Abdel Hosein, Huocong Huang, Zhaoning Wang, et al.
JCI Insight (2019) Vol. 4, Iss. 16
Open Access | Times Cited: 245
The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives
Shun Wang, Yan Zheng, Yang Feng, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 240
Chemotherapy for pancreatic cancer
Christoph Springfeld, Dirk Jäger, Markus W. Büchler, et al.
La Presse Médicale (2019) Vol. 48, Iss. 3, pp. e159-e174
Open Access | Times Cited: 237
Page 1 - Next Page

Scroll to top